(Q38161081)
Statements
Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients (English)
Duangchit Panomvana
Tharathorn Traiyawong
Somchai Towanabut
1 September 2013